You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 260 No. 19, November 18, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Glycosylated Hemoglobin Predicts the Incidence and Progression of Diabetic Retinopathy

Ronald Klein, MD, MPH; Barbara E. K. Klein, MD, MPH; Scot E. Moss, MA; Matthew D. Davis, MD; David L. DeMets, PhD

JAMA. 1988;260(19):2864-2871.


Abstract

The relationship between hyperglycemia, measured by glycosylated hemoglobin at the initial examination, and the four-year incidence and progression of diabetic retinopathy was examined in a population-based study in Wisconsin. Younger- (n = 891) and older-onset (n = 987) persons participating in baseline and follow-up examinations were included. Glycosylated hemoglobin was measured by microcolumn. Retinopathy was determined from stereoscopic fundus photographs. In the younger-onset group, comparing the highest with the lowest quartile of glycosylated hemoglobin, the relative risk for developing any diabetic retinopathy was 1.9; for proliferative retinopathy, 21.8; and for progression, 4.0. Among older-onset persons taking insulin, the corresponding relative risks were 1.9, 4.0, and 2.1. Among older-onset persons not taking insulin, relative risks were 4.0 for any retinopathy and 6.2 for progression. A positive relationship between incidence and progression of retinopathy and glycosylated hemoglobin remained after controlling for duration of diabetes, age, sex, and baseline retinopathy. These data suggest a strong and consistent relationship between hyperglycemia and incidence and progression of retinopathy.

(JAMA 1988;260:2864-2871)



Author Affiliations

From the Departments of Ophthalmology (Drs R. Klein, B. Klein, and Davis and Mr Moss) and Statistics (Dr DeMets), University of Wisconsin Medical School, Madison.


Footnotes

Reprint requests to the Department of Ophthalmology, Clinical Science Center, 600 Highland Ave, Madison, WI 53792 (Dr R. Klein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tests for Screening and Diagnosis of Type 2 Diabetes
Cox and Edelman
Clin. Diabetes 2009;27:132-138.
ABSTRACT | FULL TEXT  

The Relation of Markers of Inflammation and Endothelial Dysfunction to the Prevalence and Progression of Diabetic Retinopathy: Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein et al.
Arch Ophthalmol 2009;127:1175-1182.
ABSTRACT | FULL TEXT  

Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy
Triebel et al.
Eur J Endocrinol 2009;161:345-353.
ABSTRACT | FULL TEXT  

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
Nathan et al.
Clin. Diabetes 2009;27:4-16.
FULL TEXT  

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
Nathan et al.
Diabetes Spectr. 2009;22:6-17.
FULL TEXT  

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
Nathan et al.
Diabetes Care 2009;32:193-203.
ABSTRACT | FULL TEXT  

Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force
ANN INTERN MED 2008;148:846-854.
ABSTRACT | FULL TEXT  

Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force
Norris et al.
ANN INTERN MED 2008;148:855-868.
ABSTRACT | FULL TEXT  

Does Lowering of Blood Glucose Improve Cardiovascular Morbidity and Mortality?
Iqbal and Rubenstein
CJASN 2008;3:163-167.
FULL TEXT  

Retinal Vascular Changes in Pre-Diabetes and Prehypertension: New findings and their research and clinical implications
Nguyen et al.
Diabetes Care 2007;30:2708-2715.
FULL TEXT  

The beneficial effect of coronary-artery-bypass surgery on survival in patients with diabetic retinopathy
Ohno et al.
Eur. J. Cardiothorac. Surg. 2006;30:881-886.
ABSTRACT | FULL TEXT  

Six-year progression of retinopathy and associated risk factors in african american patients with type 1 diabetes mellitus: the new jersey 725.
Roy and Affouf
Arch Ophthalmol 2006;124:1297-1306.
ABSTRACT | FULL TEXT  

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
Nathan et al.
Diabetes Care 2006;29:1963-1972.
FULL TEXT  

The Epidemiology of Eye Disease: From Glycemia to Genetics The Friedenwald Lecture
Klein and Klein
IOVS 2006;47:1747-1753.
FULL TEXT  

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
The Diabetes Control and Complications Trial/Epide
NEJM 2005;353:2643-2653.
ABSTRACT | FULL TEXT  

Treatment of Type 2 Diabetes in Primary Health Care: A Drug Utilization Study
Mino-Leon et al.
The Annals of Pharmacotherapy 2005;39:441-445.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy
Fong et al.
Diabetes Care 2004;27:2540-2553.
FULL TEXT  

Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
Selvin et al.
ANN INTERN MED 2004;141:421-431.
ABSTRACT | FULL TEXT  

Improving Efficacy of Diabetes Management Using Treatment Algorithms in a Mainly Hispanic Population
Fanning et al.
Diabetes Care 2004;27:1638-1646.
ABSTRACT | FULL TEXT  

Effects of Aldose Reductase Inhibitors and Galactose Withdrawal on Fluorescein Angiographic Lesions in Galactose-Fed Dogs
Cusick et al.
Arch Ophthalmol 2003;121:1745-1751.
ABSTRACT | FULL TEXT  

Diabetic Patients Have an Impaired Cerebral Vasodilatory Response to Hypercapnia Under Propofol Anesthesia
Kadoi et al.
Stroke 2003;34:2399-2403.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies
Ciulla et al.
Diabetes Care 2003;26:2653-2664.
ABSTRACT | FULL TEXT  

Longitudinal Prevalence of Major Eye Diseases
Lee et al.
Arch Ophthalmol 2003;121:1303-1310.
ABSTRACT | FULL TEXT  

The Prevalence of and Factors Associated With Diabetic Retinopathy in the Australian Population
Tapp et al.
Diabetes Care 2003;26:1731-1737.
ABSTRACT | FULL TEXT  

Pharmacokinetics of Nateglinide in Renally Impaired Diabetic Patients
Devineni et al.
J Clin Pharmacol 2003;43:163-170.
ABSTRACT | FULL TEXT  

Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
Barr et al.
ANN INTERN MED 2002;137:263-272.
ABSTRACT | FULL TEXT  

The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery
Ono et al.
J Am Coll Cardiol 2002;40:428-436.
ABSTRACT | FULL TEXT  

Glycohemoglobin: A Primary Predictor of the Development or Reversal of Complications of Diabetes Mellitus
Krishnamurti and Steffes
Clin. Chem. 2001;47:1157-1165.
ABSTRACT | FULL TEXT  

Signaling Pathways for Glycated Human Serum Albumin-Induced IL-8 and MCP-1 Secretion in Human RPE Cells
Bian et al.
IOVS 2001;42:1660-1668.
ABSTRACT | FULL TEXT  

{alpha}-Dicarbonyls Increase in the Postprandial Period and Reflect the Degree of Hyperglycemia
Beisswenger et al.
Diabetes Care 2001;24:726-732.
ABSTRACT | FULL TEXT  

Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study
Chaturvedi et al.
Diabetes Care 2001;24:284-289.
ABSTRACT | FULL TEXT  

Polymorphisms of the Aldose Reductase Gene and Susceptibility to Retinopathy in Type 1 Diabetes Mellitus
Demaine et al.
IOVS 2000;41:4064-4068.
ABSTRACT | FULL TEXT  

Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project
McKay et al.
Br J Ophthalmol 2000;84:865-870.
ABSTRACT | FULL TEXT  

Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients
Giusti et al.
Br J Ophthalmol 2000;84:591-595.
ABSTRACT | FULL TEXT  

Association of Ocular Disease and Mortality in a Diabetic Population
Klein et al.
Arch Ophthalmol 1999;117:1487-1495.
ABSTRACT | FULL TEXT  

Treatment of Diabetic Retinopathy
Ferris et al.
NEJM 1999;341:667-678.
FULL TEXT  

Poor Glycemic Control Predicts Coronary Heart Disease Events in Patients With Type 1 Diabetes Without Nephropathy
Lehto et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:1014-1019.
ABSTRACT | FULL TEXT  

Prevalence and risk factors for diabetic retinopathy among Omani diabetics
Haddad and Saad
Br J Ophthalmol 1998;82:901-906.
ABSTRACT | FULL TEXT  

Is Obesity Related to Microvascular and Macrovascular Complications in Diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein et al.
Arch Intern Med 1997;157:650-656.
ABSTRACT  

Interval Between Onset of Mild Nonproliferative and Proliferative Retinopathy in Type I Diabetes
Vitale et al.
Arch Ophthalmol 1997;115:194-198.
ABSTRACT  

Cardiovascular Events and Correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes
Abraira et al.
Arch Intern Med 1997;157:181-188.
ABSTRACT  

The Pathophysiology of Diabetic Complications: How Much Does the Glucose Hypothesis Explain?
Nathan
ANN INTERN MED 1996;124:86-89.
ABSTRACT | FULL TEXT  

Glycosylated Hemoglobin and the Risk of Retinopathy in Insulin-Dependent Diabetes Mellitus
Warram et al.
NEJM 1995;332:1305-1306.
FULL TEXT  

A Comparison of the Study Populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy
Diabetes Control and Complications Trial Research et al.
Arch Intern Med 1995;155:745-754.
ABSTRACT  

Retinopathy in African Americans and Whites With Insulin-Dependent Diabetes Mellitus
Arfken et al.
Arch Intern Med 1994;154:2597-2602.
ABSTRACT  

The Association of Glycemia and Cause-Specific Mortality in a Diabetic Population
Moss et al.
Arch Intern Med 1994;154:2473-2479.
ABSTRACT  

Relationship of Hyperglycemia to the Long-term Incidence and Progression of Diabetic Retinopathy
Klein et al.
Arch Intern Med 1994;154:2169-2178.
ABSTRACT  

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
The Diabetes Control and Complications Trial Resea
NEJM 1993;329:977-986.
ABSTRACT | FULL TEXT  

Long-Term Complications of Diabetes Mellitus
Nathan
NEJM 1993;328:1676-1685.
FULL TEXT  

Screening for Diabetic Retinopathy
Singer et al.
ANN INTERN MED 1992;116:660-671.
ABSTRACT  

The Prevalence and Incidence of Lower Extremity Amputation in a Diabetic Population
Moss et al.
Arch Intern Med 1992;152:610-616.
ABSTRACT  

The Use of the Markov Process in Describing the Natural Course of Diabetic Retinopathy
Garg et al.
Arch Ophthalmol 1990;108:1245-1247.
ABSTRACT  

Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?
Haffner et al.
JAMA 1990;263:2893-2898.
ABSTRACT  

Is Blood Pressure a Predictor of the Incidence or Progression of Diabetic Retinopathy?
Klein et al.
Arch Intern Med 1989;149:2427-2432.
ABSTRACT  

Lack of Awareness and Treatment of Hyperlipidemia in Type II Diabetes in a Community Survey
Stern et al.
JAMA 1989;262:360-364.
ABSTRACT  

Screening for Diabetes Mellitus
Clement et al.
ANN INTERN MED 1989;110:572-573.
ABSTRACT  

PROGRESSION OF DIABETIC RETINOPATHY PREDICTED BY GLUCOSE CONTROL
JWatch General 1988;1988:4-4.
FULL TEXT  

Prospective Assessment of Metabolic Control in Diabetes Mellitus: The Complications Question
Stern and Haffner
JAMA 1988;260:2896-2897.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.